Insmed Incorporated (INSM)
NASDAQ
101.74
-3.49 (-3.32%)
Real-time Data
01:30 PM
Day's Range
101.60104.80
52 wk Range
90.39212.75
Financial Statements - INSM - Insmed Incorporated
Revenue
606.42M▲ 66.7%
Net Income
-1.27B▼ 39.7%Net Margin -210.5%
EBITDA
-986.38M▼ 26.4%
Free Cash Flow
-967.57M▼ 37.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 606.42M | 363.70M | 305.20M | 245.35M | 188.46M | 164.41M |
| Cost of Goods | 122.93M | 85.74M | 65.57M | 55.12M | 44.15M | 39.87M |
| Gross Profit | 483.48M | 277.96M | 239.63M | 190.23M | 144.30M | 124.54M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -994.77M | -786.57M | -680.92M | -478.12M | -367.76M | -265.23M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -193.17M | -38.58M | 15.61M | 24.41M | -28.17M | 2.10M |
| Pre Tax Income | -1.27B | -910.06M | -747.01M | -480.15M | -436.41M | -292.68M |
| Income Tax | 5.02M | 3.70M | 2.55M | 1.38M | -1.75M | 1.40M |
| Net Income | -1.27B | -913.77M | -749.56M | -481.53M | -434.65M | -294.09M |
| EPS Basic | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 |
| EPS Diluted | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 |
| Basic Shares Outstanding | 199.01M | 164.04M | 140.43M | 123.03M | 112.11M | 97.60M |
| Diluted Shares Outstanding | 199.01M | 164.04M | 140.43M | 123.03M | 112.11M | 97.60M |
| Ebit | -1.19B | -829.80M | -670.75M | -457.69M | -397.82M | -264.52M |
| Ebitda | -986.38M | -780.18M | -673.93M | -477.72M | -358.79M | -252.07M |
| Net Income Continuous Operations | -1.27B | -913.77M | -749.56M | -481.53M | -434.65M | -294.09M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
